Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
Open Access
- 31 May 2014
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 12 (3) , 273-280
Abstract
Recent evidence has associated immune and inflammatory changes to cognitive performance in many diseases, including schizophrenia. Since this is a new research field where concepts are not yet solid and new questions and hypothesis are still arising, the present study aimed at summarizing the available clinical data associating schizophrenia, cognition and inflammation/immune function. A SYSTEMATIC REVIEW OF THE LITERATURE WAS MADE BY SEARCHING THE FOLLOWING TERMS IN MEDLINE: "schizophrenia or psychosis or psychotic" AND "inflamm* or immun* or cytokine or IL-* or TNF-* or kynureni* or KYNA", AND "cognit* or attention or memory or executive function". Seventy five papers were identified using the selected terms, and seven papers were included in the review. Papers excluded focused mainly on basic research or other neuropsychiatric disorders. Recent findings link inflammatory markers to cognition in schizophrenia, suggesting that inflammation is associated with worst cognitive performance. Microglial activation, monoaminergic imbalance, brain abnormalities and the kynurenine pathway are possible mechanisms underlying cognitive impairment in schizophrenia. Clinical trials with addition of immunomodulatory drugs have shown promising results, opening new windows to tackle cognition in schizophrenia.Keywords
This publication has 52 references indexed in Scilit:
- The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disordersBritish Journal of Pharmacology, 2013
- Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkersJournal of Affective Disorders, 2012
- Progressive Gray Matter Loss and Changes in Cognitive Functioning Associated With Exposure to Herpes Simplex Virus 1 in Schizophrenia: A Longitudinal StudyAmerican Journal of Psychiatry, 2011
- Prenatal stress: Role in psychotic and depressive diseasesPsychopharmacology, 2010
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase SchizophreniaThe Journal of Clinical Psychiatry, 2009
- Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old ProblemSchizophrenia Bulletin, 2008
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative ReviewBiological Psychiatry, 2008
- Neurobiology of SchizophreniaNeuron, 2006
- SchizophreniaThe Lancet, 2004
- The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanismsMedical Hypotheses, 2001